雄激素剥夺疗法对前列腺癌患者PSMA表达及PSMA配体PET成像的影响。 - Suppr

Influence of androgen deprivation therapy on PSMA expression and PSMA-ligand PET imaging of prostate cancer patients.

作者信息

Vaz Sofia, Hadaschik Boris, Gabriel Michael, Herrmann Ken, Eiber Matthias, Costa Durval

机构信息

Nuclear Medicine Radiopharmacology, Champalimaud Centre for the Unknown, Champalimaud Foundation, Av. Brasília, 1400-038, Lisbon, Portugal.

Department of Urology, University Hospital Essen, University of Duisburg-Essen, Essen, Germany.

出版信息

Eur J Nucl Med Mol Imaging. 2020 Jan;47(1):9-15. doi: 10.1007/s00259-019-04529-8.

DOI:10.1007/s00259-019-04529-8

PMID:31654093

Abstract

摘要

相似文献

Influence of androgen deprivation therapy on PSMA expression and PSMA-ligand PET imaging of prostate cancer patients.

Eur J Nucl Med Mol Imaging. 2020 Jan;47(1):9-15. doi: 10.1007/s00259-019-04529-8.

The androgen receptor for the radiation oncologist.

Cancer Radiother. 2015 May;19(3):220-7. doi: 10.1016/j.canrad.2015.02.008. Epub 2015 Apr 23.

Heterogeneous Flare in Prostate-specific Membrane Antigen Positron Emission Tomography Tracer Uptake with Initiation of Androgen Pathway Blockade in Metastatic Prostate Cancer.

Eur Urol Oncol. 2018 May;1(1):78-82. doi: 10.1016/j.euo.2018.03.010. Epub 2018 May 15.

Combination therapy using LHRH and somatostatin analogues plus dexamethasone in androgen ablation refractory prostate cancer patients with bone involvement: a bench to bedside approach.

Expert Opin Investig Drugs. 2006 Jul;15(7):795-804. doi: 10.1517/13543784.15.7.795.

[Androgen-deprivation therapy in prostate cancer: clinical evidence and future perspectives].

Urologia. 2010 Apr-May;77(2):71-83.

Rapid Modulation of PSMA Expression by Androgen Deprivation: Serial Ga-PSMA-11 PET in Men with Hormone-Sensitive and Castrate-Resistant Prostate Cancer Commencing Androgen Blockade.

J Nucl Med. 2019 Jul;60(7):950-954. doi: 10.2967/jnumed.118.223099. Epub 2018 Dec 14.

Novel hormonal therapy for castration-resistant prostate cancer.

Ann Oncol. 2012 Sep;23 Suppl 10:x259-63. doi: 10.1093/annonc/mds362.

Efficacy of repeated PSMA PET-directed radiotherapy for oligorecurrent prostate cancer after initial curative therapy.

Strahlenther Onkol. 2020 Nov;196(11):1006-1017. doi: 10.1007/s00066-020-01629-5. Epub 2020 May 12.

[Complete hormonal block vs. simple hormonal block in the treatment of carcinoma of the prostate].

Arch Esp Urol. 2002 Sep;55(7):771-5.

Upregulation of prostate-specific membrane antigen after androgen-deprivation therapy.

Urology. 1996 Aug;48(2):326-34. doi: 10.1016/s0090-4295(96)00184-7.

引用本文的文献

The molecular blueprint of targeted radionuclide therapy.

Nat Rev Clin Oncol. 2025 Sep 9. doi: 10.1038/s41571-025-01069-z.

High-Affinity Probes for Androgen Receptor Imaging: From Cells and Modeling to Whole-Body Fluorescent Applications.

J Med Chem. 2025 Aug 14;68(15):15812-15827. doi: 10.1021/acs.jmedchem.5c00836. Epub 2025 Jul 25.

Multivariate Framework of Metabolism in Advanced Prostate Cancer Using Whole Abdominal and Pelvic Hyperpolarized C MRI-A Correlative Study with Clinical Outcomes.

Cancers (Basel). 2025 Jul 1;17(13):2211. doi: 10.3390/cancers17132211.

Impact of Concomitant Hormone Therapy on the Diagnostic Performance of F-Piflufolastat PET/CT in Prostate Cancer Patients: A Sub-Group Analysis of OSPREY Cohort B.

Prostate. 2025 Aug;85(11):1005-1015. doi: 10.1002/pros.24909. Epub 2025 May 4.

The role of PSMA-based radioligand therapy in hormone-sensitive prostate cancer.

Eur J Nucl Med Mol Imaging. 2025 Feb 12. doi: 10.1007/s00259-025-07083-8.

Molecular Hallmarks of Prostate-specific Membrane Antigen in Treatment-naïve Prostate Cancer.

Eur Urol. 2024 Dec;86(6):579-587. doi: 10.1016/j.eururo.2024.09.005. Epub 2024 Sep 17.

Prostate-Specific Membrane Antigen Biology and Pathophysiology in Prostate Carcinoma, an Update: Potential Implications for Targeted Imaging and Therapy.

Int J Mol Sci. 2024 Sep 9;25(17):9755. doi: 10.3390/ijms25179755.

PSMA-PET/CT response after metastasis-directed radiotherapy of bone oligometastases in prostate cancer.

EJNMMI Rep. 2024 Aug 19;8(1):25. doi: 10.1186/s41824-024-00212-w.

Physiological biodistribution on Ga68-PSMA PET/CT and the factors effecting biodistribution.

Ann Nucl Med. 2024 Nov;38(11):894-903. doi: 10.1007/s12149-024-01957-x. Epub 2024 Jul 9.

Prostate-Specific Membrane Antigen PET Response Associates with Metastasis-Free Survival After Stereotactic Ablative Radiation in Oligometastatic Prostate Cancer.

Adv Radiat Oncol. 2024 Apr 13;9(7):101507. doi: 10.1016/j.adro.2024.101507. eCollection 2024 Jul.

本文引用的文献

Heterogeneous Flare in Prostate-specific Membrane Antigen Positron Emission Tomography Tracer Uptake with Initiation of Androgen Pathway Blockade in Metastatic Prostate Cancer.

Eur Urol Oncol. 2018 May;1(1):78-82. doi: 10.1016/j.euo.2018.03.010. Epub 2018 May 15.

Enhancing PSMA-uptake with androgen deprivation therapy - a new way to detect prostate cancer metastases?

Int Braz J Urol. 2019 May-Jun;45(3):459-467. doi: 10.1590/S1677-5538.IBJU.2018.0305.

Rapid Modulation of PSMA Expression by Androgen Deprivation: Serial Ga-PSMA-11 PET in Men with Hormone-Sensitive and Castrate-Resistant Prostate Cancer Commencing Androgen Blockade.

J Nucl Med. 2019 Jul;60(7):950-954. doi: 10.2967/jnumed.118.223099. Epub 2018 Dec 14.

Preclinical evaluation of PSMA expression in response to androgen receptor blockade for theranostics in prostate cancer.

EJNMMI Res. 2018 Oct 29;8(1):96. doi: 10.1186/s13550-018-0451-z.

Bone Flare to Androgen Deprivation Therapy in Metastatic, Hormone-Sensitive Prostate Cancer on 68Ga-Prostate-Specific Membrane Antigen PET/CT.

Clin Nucl Med. 2018 Nov;43(11):e404-e406. doi: 10.1097/RLU.0000000000002273.

Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries.

CA Cancer J Clin. 2018 Nov;68(6):394-424. doi: 10.3322/caac.21492. Epub 2018 Sep 12.

Impact of long-term androgen deprivation therapy on PSMA ligand PET/CT in patients with castration-sensitive prostate cancer.

Eur J Nucl Med Mol Imaging. 2018 Nov;45(12):2045-2054. doi: 10.1007/s00259-018-4079-z. Epub 2018 Jul 7.

Pharmacological upregulation of prostate-specific membrane antigen (PSMA) expression in prostate cancer cells.

Prostate. 2018 Jul;78(10):758-765. doi: 10.1002/pros.23522. Epub 2018 Apr 6.

Efficacy, Predictive Factors, and Prediction Nomograms for Ga-labeled Prostate-specific Membrane Antigen-ligand Positron-emission Tomography/Computed Tomography in Early Biochemical Recurrent Prostate Cancer After Radical Prostatectomy.

Eur Urol. 2018 May;73(5):656-661. doi: 10.1016/j.eururo.2018.01.006. Epub 2018 Jan 19.

Influence of Androgen Deprivation Therapy on the Uptake of PSMA-Targeted Agents: Emerging Opportunities and Challenges.

Nucl Med Mol Imaging. 2017 Sep;51(3):202-211. doi: 10.1007/s13139-016-0439-4. Epub 2016 Aug 6.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

Influence of androgen deprivation therapy on PSMA expression and PSMA-ligand PET imaging of prostate cancer patients.

作者信息

机构信息

出版信息

相似文献

引用本文的文献

本文引用的文献

文献AI研究员

用中文搜PubMed

文档翻译

Suppr 超能文献

相似文献

引用本文的文献

本文引用的文献